| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |